Clinical uses of intravenous immunoglobulin. (Q36264883)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Clinical uses of intravenous immunoglobulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

W A C Sewell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S A Misbah

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1-11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

7 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Natural antibodies sustain differentiation and maturation of human dendritic cells

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Treatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Increased risk of adverse events when changing intravenous immunoglobulin preparations

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin for Guillain-Barré syndrome

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin for suspected or subsequently proven infection in neonates

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Scleromyxoedema: treatment of cutaneous and systemic manifestations with high-dose intravenous immunoglobulin

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin for the treatment of Kawasaki disease in children

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulins for multiple sclerosis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Risks associated with the use of intravenous immunoglobulin

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Immunomodulatory action of intravenous immunoglobulin.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Psoriasis: response to high-dose intravenous immunoglobulin in three patients.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Gamma-globulins prepared from sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Disease severity in multifocal motor neuropathy and its association with the response to immunoglobulin treatment

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulins control scleromyxoedema

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Polyspecific immunoglobulins (IVIg) suppress proliferation of human (auto)antigen-specific T cells without inducing apoptosis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Prophylactic antibiotics for the prevention of early infection in multiple myeloma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Monoclonal antibody 197 (anti-Fc gamma RI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down-modulation of Fc gamma RI on circulating monocytes

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

In vitro effects of polyvalent immunoglobulin for intravenous use.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. The UK Group for Immunoglobulin Replacement Therapy in Multiple Myeloma

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Comparative safety and efficacy of two immune globulin products in Kawasaki disease

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Intravenous immunoglobulin therapy for antibody deficiency

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809480

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02834.X

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2005.02834.X

Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro

21 January 2018

1 reference

12 December 2020

Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG

1 reference

12 December 2020

Immunologically active proteins in intravenous immunoglobulin

1 reference

12 December 2020

Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo

1 reference

12 December 2020

Intravenous immune globulin in chronic lymphocytic leukaemia

1 reference

12 December 2020

Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta-1a

1 reference

12 December 2020

Intravenous immunoglobulin in autoimmune chronic urticaria

1 reference

12 December 2020

High-dose intravenous immunoglobulin treatment activates complement in vivo

1 reference

12 December 2020

Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin

1 reference

12 December 2020

The blistering diseases

1 reference

12 December 2020

The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile

1 reference

12 December 2020

The treatment of refractory uveitis with intravenous immunoglobulin

1 reference

12 December 2020

Inhibition of cell adhesion by antibodies to Arg-Gly-Asp (RGD) in normal immunoglobulin for therapeutic use (intravenous immunoglobulin, IVIg)

1 reference

12 December 2020

Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis

1 reference

12 December 2020

Pulmonary abnormalities in patients with primary hypogammaglobulinemia

1 reference

12 December 2020

[Post-traumatic pyoderma gangrenosum: combination therapy with intravenous immunoglobulins and systemic corticosteroids]

1 reference

12 December 2020

An enzyme immunoassay to determine the levels of specific antibodies toward bacterial surface antigens in human immunoglobulin preparations and blood serum

1 reference

12 December 2020

High-dose intravenous immune globulin is also effective in linear IgA disease

1 reference

12 December 2020

Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group

1 reference

12 December 2020

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity

1 reference

12 December 2020

Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg)

1 reference

12 December 2020

Are IVIG for chronic unremitting urticaria effective?

1 reference

12 December 2020

Intravenous immunoglobulin therapy influences T cell adhesion to extracellular matrix in women with a history of recurrent spontaneous abortions

1 reference

12 December 2020

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Respiratory disorders in common variable immunodeficiency

1 reference

12 December 2020

Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo

1 reference

12 December 2020

Efficacy of human intravenous immune globulin in pyoderma gangrenosum

1 reference

12 December 2020

Pretibial myxedema and high-dose intravenous immunoglobulin treatment

1 reference

12 December 2020

In vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins

1 reference

12 December 2020

Anti-CD4 activity of normal human immunoglobulin G for therapeutic use. (Intravenous immunoglobulin, IVIg)

1 reference

12 December 2020

Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production

1 reference

12 December 2020

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

1 reference

12 December 2020

Relationship of the dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency

1 reference

12 December 2020

Intravenous immunoglobulin as sole therapy for systemic vasculitis

1 reference

12 December 2020

Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro

1 reference

12 December 2020

High-Dose Intravenous Immune Globulin for Stiff-Person Syndrome

1 reference

12 December 2020

Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency

1 reference

12 December 2020

High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders

1 reference

12 December 2020

Annular crystalline keratopathy in association with immunoglobulin therapy for pyoderma gangrenosum

1 reference

12 December 2020

Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases

1 reference

12 December 2020

Superficial granulomatous pyoderma treated with intravenous immunoglobulin

1 reference

12 December 2020

Lack of response of elephantiasic pretibial myxoedema to treatment with high-dose intravenous immunoglobulins

1 reference

12 December 2020

IgG Subclasses in Human γ-Globulin Preparations for Intravenous Use and Their Reactivity with Staphylococcus Protein A

1 reference

12 December 2020

Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A

1 reference

12 December 2020

Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial

1 reference

12 December 2020

Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS

1 reference

12 December 2020

Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease

1 reference

12 December 2020

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

12 December 2020

Evidence for immunosuppression by high-dose gammaglobulin

1 reference

12 December 2020

High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease

1 reference

12 December 2020

Enzyme-linked immunosorbent assay (ELISA) for human tumor necrosis factor (hTNF)

1 reference

12 December 2020

Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models

1 reference

12 December 2020

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

1 reference

12 December 2020

Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia

1 reference

12 December 2020

Unusual Spindle Cell Squamous Carcinoma in a Renal Transplant Patient

1 reference

12 December 2020

10.1111/J.1365-2249.2005.02834.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16178850%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

PMC publication ID

1809480

0 references

1 reference